About This 510(k) Submission
K232294 is an FDA 510(k) clearance for the HemoSphere Alta Advanced Monitoring Platform; HemoSphere Alta? Advanced Monitor (Smart Recovery); HemoSphere Alta? Advanced Monitor (Cardiac); HemoSphere Alta? Advanced Monitor (All-on-One), a Computer, Diagnostic, Programmable (Class II — Special Controls, product code DQK), submitted by Edwards Lifesciences, LLC (Irvine, US). The FDA issued a Cleared decision on October 31, 2023, 91 days after receiving the submission on August 1, 2023. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1425.